HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ashenafi Bulle Selected Research

Acriflavine

1/2020Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts.
1/2019Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts.
2/2017Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ashenafi Bulle Research Topics

Disease

5Neoplasms (Cancer)
10/2020 - 02/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2020 - 02/2017
3Adenocarcinoma
03/2020 - 01/2019
1Inflammation (Inflammations)
09/2020
1Liver Neoplasms (Liver Cancer)
02/2017
1Hypoxia (Hypoxemia)
02/2017

Drug/Important Bio-Agent (IBA)

3RNA (Ribonucleic Acid)IBA
03/2020 - 01/2019
3AcriflavineIBA
01/2020 - 02/2017
2GemcitabineFDA Link
03/2020 - 01/2019
2Pharmaceutical PreparationsIBA
01/2020 - 01/2019
1Transcription Factors (Transcription Factor)IBA
09/2020
1CytokinesIBA
03/2020
1Biological ProductsIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
02/2017
1Sorafenib (BAY 43-9006)FDA Link
02/2017
1cobaltous chloride (cobalt(II)chloride)IBA
02/2017

Therapy/Procedure

3Therapeutics
10/2020 - 01/2020
1Drug Therapy (Chemotherapy)
03/2020